Atlas Trials

Lenalidomide & High Dose Dexamethasone for Untreated Multiple Myeloma Renal Failure Patients

Clinical trial NCT01270932 · COMPLETED

Trial details

NCT number
NCT01270932
Sponsor
University Health Network, Toronto
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Renal FailureMultiple Myeloma
Start date
2010-11-01
Primary completion
2017-12-18
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.